🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07128953
Enrolling by invitation Phase EARLY_PHASE1

Study on the Mechanism of Zuoqing San Promoting Postoperative Wound Healing of Anal Fistula by Inhibiting ROS-dependent NETosis

NCT07128953 · tracked via the Priya Life Science China tracker
Sponsor
The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Phase
Phase EARLY_PHASE1
Started
2025-08-01
Last updated
2025-08-19

Condition(s) studied

Anal Fistula

Investigational drug(s) / intervention(s)

Solution of Zuoqing San for fumigation and washing of the postoperative wound of anal fistulaEqual-volume placebo inhalation rinse

Solution of Zuoqing San for fumigation and washing of the postoperative wound of anal fistula: Left Qing San Decoction (25g of Cai Yin + 30g of Eucommia + 25g of Sophora flavescens + 25g of Anemarrhena asphodeloides + 15g of Lithospermum erythrorhizon, prepared in the Pharmacy Department of Anhui University of Traditional Chinese Medicine), add 1000mL of water, boil, then steam and wash the wound surface. The temperature is 40 ± 2℃. Do it once a day, for 15 minutes each time, for 7 consecutive days.

Equal-volume placebo inhalation rinse: Equal-volume placebo inhalation rinse

Study summary

This study adopted a randomized, double-blind, placebo-controlled clinical trial design to evaluate the efficacy and safety of Zuoqing San fumigation and washing on the wound healing after anal fistula surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Recurrent swelling and pain, along with pus discharge around the anus; * Preoperative MRI or ultrasound confirmed the presence of the fistula; * Underwent incision of the anal fistula, with the postoperative wound diameter ranging from 2 to 4 cm. Exclusion Criteria: 1. Inflammatory bowel disease (such as Crohn's disease) related anal fistula; 2. Complicated with severe dysfunction of heart, liver and kidney (ALT/AST \> 2 times upper limit, Cr \> 1.5 mg/dL); 3. Pregnant or lactating women; 4. Those who are known to be allergic to the components of Zuoqing San;

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Anhui university of Chinese Medicine Hefei Anhui

More The Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07128953 on ClinicalTrials.gov ↗ ← All trials in China